Bioretec Oy announced an equity round of funding for gross proceeds of 749,999 on January 3, 2013. The securities will be issued pursuant to Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 EUR | +0.69% |
|
-0.34% | +20.83% |
28/06 | Bioretec Flags Delay in Receipt of European CE Mark for Trauma Screw | MT |
19/06 | Bioretec Ltd. Reports Successful Clinical Outcomes from U.S. Controlled Launch of RemeOs Trauma Screw | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.83% | 6.45Cr | |
+75.69% | 1.26TCr | |
-19.21% | 787.78Cr | |
-7.03% | 579.53Cr | |
+10.32% | 526.46Cr | |
-16.50% | 483.84Cr | |
-11.84% | 436.7Cr | |
+17.06% | 419.08Cr | |
-9.70% | 340.81Cr | |
+28.00% | 205.64Cr |
- Stock Market
- Equities
- BRETEC Stock
- News Bioretec Oy
- Bioretec Oy announced that it expects to receive €0.75 million in funding.